A Clinician View and Experience of Proteomic Studies in the Light of Lung Cancer in Japanese Healthcare
| Autor: | Kiyonaga Fujii, Toshihide Nishimura, Sayaka Mikami, Yasuhiko Bando, Masahiro Tsuboi, Takeshi Kawamura, Norihiko Ikeda, Makoto Kihara, György Marko-Varga, Masaharu Nomura, Takashi Hirano, Hiromasa Tojo, Harubumi Kato |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Adult
Male Proteomics medicine.medical_specialty Lung Neoplasms Protein biomarkers Bioinformatics Biochemistry Japan Health care Biomarkers Tumor medicine Humans Medical prescription Intensive care medicine Lung cancer Aged business.industry Medical evaluation General Chemistry Middle Aged Prognosis medicine.disease Biomarker (cell) ROC Curve Area Under Curve Female business Delivery of Health Care Healthcare system |
| Zdroj: | Journal of Proteome Research. 10:51-57 |
| ISSN: | 1535-3907 1535-3893 |
| Popis: | In Japan, rising costs have impacted the framework of maintaining an efficient and effective healthcare system. Today, urgent implementation of programs to address this need have led to a rebuilding of the entire approach of medical evaluation and clinical care. Recent developments in clinical proteomics based on mass spectrometry (MS) for identifying, sequencing, and quantifying disease-relevant protein biomarkers is a promising means for optimal drug prescription using biomarker diagnosis. We illustrate in this report our experience with lung cancer cases with various drug therapies evaluated with proteomics studies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|